Breast Cancer Treatment at CritiCare Asia Hospitals, Andheri East
Breast cancer begins when cells in breast tissue divide abnormally and form a tumour that can grow locally or spread beyond the breast. It most often starts in the milk ducts or lobules. About 1 in 28 women in India is at risk over a lifetime. CritiCare Asia Hospitals, a breast cancer hospital in Mumbai, treats it as a highly treatable disease when found early. Our team provides breast cancer treatment in Andheri East, Mumbai, from screening through recovery.
Symptoms of Breast Cancer
A lump is not the only sign, and relying on it can delay diagnosis.
A lump or thickened area unlike the surrounding tissue
Nipple discharge, particularly if blood-tinged
Nipple retraction or inversion that is new
Skin dimpling or orange-peel texture
Swelling or a new lump in the armpit
Changes in breast size, shape or skin texture
Any persistent change warrants evaluation. The best oncologists in Mumbai at our hospital can assess it promptly.
Screening
- Clinical breast exam, including the armpit lymph nodes
- Mammography, the primary screening tool, with timing based on personal risk
- Breast self-exam, to notice changes between scheduled screenings
- MRI for women at high genetic or familial risk, alongside mammography
Where the case allows, consultation and screening imaging can be completed in a single visit.
Diagnosis
A core needle biopsy provides tissue for a definitive diagnosis. It is analysed for cell type, grade and estrogen, progesterone and HER2 receptor status, which direct the treatment. Women with a strong family history are offered genetic counselling to decide on BRCA or other hereditary testing. Our oncologists and breast cancer surgeons in Andheri East, Mumbai review the results together.
Types of Breast Cancer
- Ductal carcinoma in situ (DCIS): non-invasive and confined to the milk ducts
- Invasive ductal carcinoma: the most common, spreading into surrounding tissue
- Invasive lobular carcinoma: starts in the lobules and can be harder to see on mammography
- Triple-negative breast cancer: lacks estrogen, progesterone, and HER2 receptors
- HER2-positive breast cancer: driven by excess HER2 protein, treated with HER2-targeted therapy
- Inflammatory breast cancer: rare, fast-moving, causing redness and swelling instead of a lump
Risk Factors
Inherited BRCA1 and BRCA2 mutations significantly raise lifetime risk, though only 5 to 10 percent of breast cancers trace to an inherited mutation. Other factors are early menarche or late menopause, no full-term pregnancy, long-term postmenopausal hormone therapy, and dense breast tissue. Family history, obesity and alcohol contribute less. Most women have a mix of factors, so screening matters whatever the family history.
Treatment Options for Breast Cancer
Treatment depends on type, stage, grade and receptor status, and is often combined.
Breast-conserving surgery, removing the tumour and a margin of healthy tissue
Mastectomy, sometimes extended to the opposite breast for high genetic risk
Sentinel lymph node biopsy, often avoiding more extensive node removal
Radiation therapy, commonly after breast-conserving surgery
Chemotherapy, before or after surgery
Hormone therapy for receptor-driven cancers
Targeted therapy (trastuzumab) for HER2-positive cancers
Reconstruction at the time of mastectomy or later
Our team can advise on breast cancer surgery in Andheri East, Mumbai.
Breast Cancer Treatment at CritiCare Asia Hospitals, Andheri East
At CritiCare Asia Hospitals, a leading breast cancer hospital in Andheri East, Mumbai, treatment begins with a complete diagnostic picture of biopsy, receptor testing and imaging, scheduled in a clear order before any plan is finalised. The oncology team weighs breast-conserving surgery against mastectomy by tumour characteristics and patient preference, and sequences chemotherapy, radiation or hormone therapy by receptor status and stage. Reconstruction is discussed during surgical planning. If you have noticed a lump, skin change or nipple discharge, speak with our oncology team for prompt evaluation.